Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT06446635
Other study ID # 81105
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date April 14, 2023
Est. completion date August 1, 2025

Study information

Verified date May 2024
Source Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Contact AJM Pronk
Phone +31642665328
Email a.pronk@amsterdamumc.nl
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Rationale: Perianal fistulas are a common, invalidating problem for which a more effective and widely applicable treatment is necessary. Vacuum therapy has become one of the main pillars for management of a wide variety of (chronic) wound healing problems. A novel catheter set was developed for vacuum therapy of perianal abscesses/sinuses and fistulas: The Semiflex Dome System. This system will allow for a better and faster treatment and it will offer conformability with various fistula shapes and sizes. Objective: With this pilot study, the investigators aim to test our novel catheter set for vacuum therapy of perianal abscesses/sinuses and fistulas for feasibility and efficacy. Study design: The design of this prospective, multicentre study is a feasibility study. Study population: Patients (≥ 18 years) with (Crohn's) perianal fistulas and patients with perianal abscesses/sinuses are eligible. Intervention: A tailored (length and diameter) Semiflex dome catheter is inserted under general anaesthesia, after 6 weeks of seton drainage in patients with a perianal fistula and right away in patients with a perianal abscess/sinus. The catheter is fixed on a Renasys Adhesive gel patch (Smith and Nephew) and is connected with a tubing system to a vacuum pomp with an average vacuum pressure of 80 cm H2O. After two - three days the catheter will be exchanged by a shorter catheter in the outpatient setting. The therapy is continued for a maximum of four weeks in patients with a perianal abscess/sinus and two weeks in patients with perianal fistulas. Main study parameters/endpoints: The primary objective of the study is the feasibility of the methodology with respect to smoothness of insertion and changing the semiflex catheters, capability of proper fixation of the catheter and maintaining vacuum for more than 48 hours, and compliance to the therapy in terms of pain and discomfort. Secondary objectives are efficacy of drainage of the perianal abscess/sinus, efficacy of curing the perianal abscess/sinus in terms of complete collapse of the sinus and disappearance of induration, efficacy of management of perianal fistula in terms of clinical and radiological healing, and safety in terms of complications. Nature and extent of the burden and risks associated with participation: The Semiflex Dome Catheter System will be placed in patients with perianal fistulas and perianal abscess/sinus who would otherwise be treated using prior-art passive drainage catheters or repurposed vacuum-assisted closure therapy sponges. There are no known additional risks stemming from the proposed therapy. The Semiflex Dome Catheter System is made entirely of medical-grade silicone certified with ISO 10993- 05 and ISO 10993-10. The catheters will be connected with a tube configured to be connected to a CE certified vacuum generating system. Sample size: Since this is a pilot study no sample size is required. The pilot study will consist of 2 parts. In the first part, 10 patients in each study group will be included and it will be assessed per study group if the catheter meets the proof of principle. After a positive result in one or both study groups, the second part of the study will start. 10 patients in each study group will be included. The proposed treatment protocol is considered feasible if at least 70% of the Semiflex dome catheter treatment per study group meets the four primary objectives.


Recruitment information / eligibility

Status Recruiting
Enrollment 40
Est. completion date August 1, 2025
Est. primary completion date May 1, 2025
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 80 Years
Eligibility Inclusion criteria - Perianal abscess/sinus or (Crohn's) perianal fistula - = 18 years and < 80 years - Written informed consent Exclusion criteria - Patients with more than 2 external perianal openings - Rectovaginal fistula - Life expectancy < 2 years - Dementia or altered mental status that would prohibit the understanding and giving of informed consent

Study Design


Intervention

Device:
Semiflex Dome Catheter System
Abces: In patients that present with a perianal abscess/sinus the semiflex dome catheter is inserted under general anesthesia. A small cut is made to drain and irrigate the septic sinus. Fistula: Under general anesthesia the seton is removed, the internal opening is excised and the internal opening is closed with a 2-0 Vicryl cross stitch. Both: Before surgery, the length of the tract is measured on MRI or CT. A Semiflex Catheter with the appropriate length and a diameter is selected. If during surgery appears that this is not the appropriate size, a different size catheter can be used. The catheter is fixed on a Renasys Adhesive gel patch (Smith and Nephew). The catheter is connected with a tubing system to a vacuum pomp with an average vacuum pressure of 80 cm H2O. The tube will be taped on the patient. After every 2-3 days the catheter will be exchanged by a 3-6 mm shorter catheter.

Locations

Country Name City State
Netherlands Amsterdam UMC Amsterdam

Sponsors (1)

Lead Sponsor Collaborator
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

Country where clinical trial is conducted

Netherlands, 

Outcome

Type Measure Description Time frame Safety issue
Primary Smoothness of insertion and exchanging of the Semiflex catheter The doctor will determine how easy the catheter is to insert on a scale of 0-10, with 0 being very difficult and 10 being very easy. A score <5 is considered as not smooth. This will be scored individually and if all primary outcome measures are met, the treatment is considered successful in this participant. 3 months
Primary Proper fixation of the Semiflex catheter The system is properly fixed if it has been in place for >48 hours. If the system becomes loose before 48 hours, it is considered as not properly fixed. This will be scored individually and if all primary outcome measures are met, the treatment is considered successful in this participant. 48 hours
Primary Maintaining vacuum for more than 48 hours The system is properly vaccuum if it has been vacuum for >48 hours. If the system looses vaccuum before 48 hours, it is considered as not properly vaccuum. This will be scored individually and if all primary outcome measures are met, the treatment is considered successful in this participant. 48 hours
Primary Compliance to the therapy in terms of pain and discomfort The patient gives a painscore after the Semiflex exchange on a scale of 0-10, with 0 being not painfull and 10 being very painfull. A score >5 is considered as too painfull. This will be scored individually and if all primary outcome measures are met, the treatment is considered successful in this participant. 3 months
Secondary Efficacy of drainage of the perianal abscess/sinus Is the Semiflex capable of draining the perianal abcess/sinus. 1 month after therapy a clinical evaluation will be done to see if the perianal abscess/ sinus is healed. Clinical closure is defined as closure of the external opening without discharge of pus on palpation. After three months a MRI is made to see if the perianal abscess/sinus is radiological healed. Radiological healing defined as complete fibrosis of the abscess/sinus on MRI. 3 months
Secondary Efficacy of management of perianal fistula in terms of clinical and radiological healing Is the Semiflex capable of draining the perianal fistula. 1 month after therapy a clinical evaluation will be done to see if the perianal fistula is healed. Clinical closure is defined as closure of the external opening without discharge of pus or feaces on palpation. After three months a MRI is made to see if the perianal fistula is radiological healed. Radiological healing defined as complete fibrosis of the perianal fistual. 3 months
Secondary Safety in terms of complications All complications related to the Semiflex treatment will be recorded during the follow-up of three months. 3 months
See also
  Status Clinical Trial Phase
Recruiting NCT03913572 - Treatment of Perianal Disease Using Adipose-derived Stem Cells
Terminated NCT01623453 - Follow-up Study of Autologous Adipose-derived Stem Cells (ANTG-ASC) for the Complex Fistula (ANTG-ASC-211) N/A
Completed NCT06441526 - Surgical Closure vs Anti-TNF in the Treatment of Perianal Fistulas in Crohn's Disease (PISA-II): a Comprehensive Cohort Design Phase 3
Recruiting NCT04847739 - Seeded Cells on Matrix Plug Treating Crohn's Perianal Fistulas (STOMP-II) Phase 2
Completed NCT06314945 - Diagnostic Value of Recto-perineal Ultrasound in Perianal Fistula
Completed NCT03763981 - Comparison of Prolene Thread Seton Vs Silk Thread Seton for the Treatment of Perianal Fistula N/A
Not yet recruiting NCT05626023 - A Study of Human TH-SC01 Cell Injection for Treating Perianal Fistulas in Patients With Crohn's Disease Phase 1/Phase 2
Completed NCT01021774 - Anal Fistula Treatment Outcome - Collagen Plug Versus Advancement Flap Surgery N/A
Recruiting NCT04519671 - Mesenchymal Stem Cells for the Treatment of Perianal Fistulizing Crohn's Disease Phase 1/Phase 2
Active, not recruiting NCT04549311 - Perianal Abscess Recurrence and Fistula Formation: Antibiotics Following Incision and Drainage Trial Phase 3
Completed NCT03555773 - Micro-fragmented Adipose Tissue and Complex Crohns' Anal Fistulas N/A
Recruiting NCT03707769 - TIPS Microspheres for Perianal Fistula N/A
Completed NCT03803917 - Adipose Tissue in Crohn´s Disease Fistulas N/A
Recruiting NCT03322488 - Fistulodesis Pilot Study for Closure of Perianal Fistulae N/A
Withdrawn NCT03014219 - Phase 1 Crohn's Pediatric Sub-study of MSC AFP Phase 1
Completed NCT03209700 - Re-treatment From a Phase I Study of MSC-AFP in Patients With Perianal Fistulas Phase 1
Completed NCT03981939 - Perianal Fistula (PAF) Validation and Burden of Illness Study
Recruiting NCT05721794 - Comparative Accuracy of Transperineal Ultrasound (TPUS) Versus Magnetic Resonance Imaging (MRI) for the Assessment of Perianal Fistulae in Patients With Crohn's Disease (CD): a Prospective Observational Longitudinal Cohort Study
Enrolling by invitation NCT03861689 - Tight Control Management in Perianal Crohn's Disease N/A
Not yet recruiting NCT05709717 - Regenerative Therapy With Autologous Stromal Vascular Fraction Derived Mesenchymal Stem Cells and Platelet-rich Plasma to Treat Complex Perianal Diseases